Uniform with the effects of PDE5 inhibition on the nitric oxide/cyclic guanosine monophosphate pathway, PDE5 inhibitors, including LEVITRA, May potentiate the hypotensive personal effects of nitrates. A appropriate prison term time interval undermentioned dosing of LEVITRA for the safe governing body of nitrates or chemical element oxide donors has not been set. Inform patients that
